Novo Nordisk und BYD verkaufen?
1 extracted signal · 0 resolved · 1 still active
Wir Lieben Aktien GmbHIndependent analyst profile- Source published
- 25 Sept 2026, 19:37 UTC
- Recorded by Tahlil Plus
- 25 Sept 2026, 23:04 UTC
AI-generated source summary
The analysis focuses on individual stock positions within a portfolio. For Novo Nordisk (NOVOBANK), the outlook is bullish, with an inferred target of 1250 and a fail bound set at 1050. BYD is also viewed positively with a bullish prediction, an inferred target of 550, and a fail bound at 400. Pepsi (PEP) shares are expected to rise, with a target of 145 and a fail bound at 120. Alphabet (ALFA) is currently showing a bearish trend but is predicted to turn bullish, with an inferred target of 1850 and a fail bound at 1650. ServiceNow (SNOW) is also considered bullish, with a target of 2800 and a fail bound at 2400. The speaker mentions that the position sizing for some stocks like Pepsi and BYD might be riskier and questions their fit within the overall strategy, but ultimately deems the general situation for both Novo Nordisk and BYD as positive at fair valuations. The speaker also notes that for BYD, a proper entry and a mid-term bottom are crucial for new buy signals. The overall sentiment for the analyzed stocks is generally bullish, contingent on specific price levels and strategic considerations.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Wir Lieben Aktien GmbH
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.